The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

7 Jun 2018 07:00

RNS Number : 5676Q
Sopheon PLC
07 June 2018
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

At today's Annual General Meeting of Sopheon, the international provider of software and services that help organizations generate more revenues and profits from new products, the Board will give shareholders an update and review of the business.

 

In conjunction with a truly exceptional financial performance in 2017, we continue to advance our strategy to be the world's leading provider of enterprise-class innovation management solutions. Our vision has consistently led the market, and this is a market that continues to evolve and demonstrate considerable growth. We delivered a very strong finish to last year, resulting in all the Group's headline financial measures exceeding market expectations by a significant margin. Revenues rose to $28.5m from $23.2m in 2016. On the back of an already strong increase in profitability in 2016, EBITDA last year reached $8.0m, up from $5.6m the year before, and profit before tax was $5.1m, compared to $3.0m the year before. Alongside a realignment of our debt position, this resulted in net assets rising to $18.6m from $10.4m the year before, and net cash rising to $9.5m from $4.2m.

 

Both volume and average value of license transactions increased compared to the year before. Towards the end of 2017 we signed substantial deals with two industry leading, blue chip, companies in the USA and in Germany and we are now in the process of implementing our Accolade® solution globally in both cases. Such customers further validate the momentum and acceptance of Accolade as an enterprise platform within the largest and most influential corporations in the world. We saw more acceptance of our SaaS (Software as a Service) offering, with three new SaaS customers signed last year, and our recurring revenue base improved to over $12m by the end of the year compared to just under $10m the year before.

 

Sopheon's market differentiation continues to be validated. Sopheon is the only vendor recognized in three different Gartner Market Guides - for Strategy Execution Management Software; Innovation Management Tools; and Strategy & Innovation Roadmapping Tools - as well as in its Magic Quadrant for Project Portfolio Management Worldwide. In our view, the capabilities called for in all of these respective reports are required to deliver on the promise of connecting strategic planning and operational execution. In addition, Sopheon was named a Leader in the 2017 Forrester Wave™: Strategic Portfolio Management Tools. Further recent market validation was recognition by Consumer Goods Technology magazine, naming Sopheon as "Best in Category" in new product development and introduction as voted by readers. Collectively, these are major strategic milestones in establishing the credentials of both the Company and our market.

 

In order to deliver on our growth strategies as described in our annual report, we are executing on ambitious investment plans across multiple functional areas to scale for growth for 2018 and beyond. Where appropriate, we are also open to consideration of targeted M&A opportunities if consistent with our goals and focused investment criteria. Alongside strategic initiatives, we remain highly driven by revenue and profit objectives, and to stand behind this ambition we have proposed a maiden dividend, to be put to the Company's shareholders at today's meeting. Remaining on the corporate theme, we were delighted with the success of our oversubscribed secondary placing completed in mid-May, which expanded our institutional shareholder base and we are grateful for the support and demand shown by certain blue chip institutional investors for the Company's shares.

 

Outlook

 

The positive momentum has continued this year, and we are signing additional new business which in turn is underpinning the performance for the year. Full year revenue visibility for 2018 from contracted business and recurring revenue streams is now up 34% at $23.5m, compared to $17.5m at this time last year - an all-time high for our mid-year AGM report. This includes the effect of several perpetual license deals and major services extensions, as well as a further major SaaS deal closed during the current quarter.

 

The Board continues to be confident and enthusiastic about the prospects of the Company, the outturn for the year and the opportunity to continue to deliver on our vision.

 

 

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Giles Rolls (corporate finance)

Alice Lane (corporate broking)

finnCap

+ 44 (0) 20 7220 0500

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMLLFERRVIRIIT
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSDirectors' Options
1st Oct 20127:00 amRNSHolding(s) in Company
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.